Clinical and basic studies of functional interactions between adaptive immunity, affective states, and brain function are reviewed, and the neural, humoral, and cellular routes of bidirectional communication between the brain and the adaptive immune system are evaluated. In clinical studies of depressed populations, lymphocytes-the principal cells of the adaptive immune system-exhibit altered T cell subtype ratios and CD4 + helper T cell polarization profiles. In basic studies using psychological stress to model depression, T cell profiles are altered as well, consistent with stress effects conveyed by the hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Lymphocytes in turn have effects on behavior and CNS structure and function. CD4 + T cells in particular appear to modify affective behavior and rates of hippocampal dentate gyrus neurogenesis. These observations force the question of how such actions are carried out. CNS effects may occur via cellular and molecular mechanisms whereby effector memory T cells and the cytokine profiles they produce in the blood interact with the bloodbrain barrier in ways that remain to be clarified. Understanding the mechanisms by which T cells polarize and interact with the brain to alter mood states is key to advances in the field, and may permit development of therapies that target cells in the periphery, thus bypassing problems associated with bioavailability of drugs within the brain. Published by Elsevier Inc.
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Introduction
Converging evidence from multiple clinical and experimental lines of research supports a role for the peripheral immune system in the etiology and maintenance of depressive disorders. Support for this role is based on the following: 1) recent evidence from genome-wide association studies show prominent links between immune gene variants and mood disorders (Bufalino et al., 2013; Network and Pathway Analysis Subgroup of Psychiatric Genomics, 2015; Wong et al., 2008) ; 2) autoimmune diseases, infections, and other inflammatory diseases are comorbid with depression (Benros et al., 2013; Maes, 2011) ; 3) immune system molecules such as cytokines are elevated in depressed patients (Baumeister et al., 2014; Capuron and Dantzer, 2003; Dowlati et al., 2010; Dunn et al., 2005; Felger and Lotrich, 2013; Liu et al., 2012; Zunszain et al., 2013) ; 4) depression symptoms are induced following therapeutic administration of the cytokines interleukin-2 (IL-2) or interferon α (Raison et al., 2009); and 5) proinflammatory cytokines produce sickness behavior in animals that is reminiscent of depression by several criteria such as fatigue, anhedonia, changes in appetite, and sleep disturbances (Dantzer, 2012; Dantzer et al., 2008) .
While there are excellent reviews on the subject of brain-immune interactions underlying psychiatric disorders (Haapakoski et al., 2016; Maier and Watkins, 1998; Najjar et al., 2013) , we will focus more specifically on interactions between the brain and the adaptive immune system, which has only recently received attention in relation to mental health. The adaptive immune system is one of two functionally distinct arms of what is collectively called the peripheral immune system (Fig. 1) . The first arm is the innate immune system, including monocytes and other cells of the myeloid lineage that rapidly respond to pathogenic challenges. The second arm is the adaptive immune system, comprising lymphocytes that exhibit a delayed response in the face of inflammatory challenge during which adaptation and commitment (polarization) of lymphocytes occur to generate cellular memory for pathogens. Abbreviations: PCs, antigen presenting cells; BBB, blood-brain barrier; BDNF, brain derived neurotropic factor; CNS, central nervous system; CSF, cerebrospinal fluid; CRH, corticotropin releasing hormone; DG, dentate gyrus; HPA, hypothalamic pituitary adrenal; IFNγ, interferon γ; IL, interleukin; MBP, myelin basic protein; PVN, paraventricular nucleus; SCID, severe combined immunodeficiency; SNS, sympathetic nervous system; Tcm, T cells, central memory; Treg, T regulatory cell; TGFβ, transforming growth factor β.
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